Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cappelli

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
European Heart Journal|January 18, 2020
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosisLiza Chacko, Raffaele Martone, Francesco Bandera, et al.
JACC. Cardiovascular Imaging|August 22, 2021
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin AmyloidosisFrancesco Bandera, Raffaele Martone, Liza Chacko, et al.
Giornale Italiano Di Cardiologia (2006)|February 3, 2023
[Rationale and significance of the Italian Network for Cardiac Amyloidosis]Gianfranco Sinagra, Michele Emdin, Marco Merlo, et al.
Circulation. Heart Failure|February 24, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac AmyloidosisMattia Zampieri, Giulia Biagioni, Annamaria Del Franco, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Circulation. Heart Failure|May 15, 2025
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid CardiomyopathyLaura De Michieli, Giulio Sinigiani, Gianluigi Guida, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 5, 2023
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY studyAlberto Aimo, Lucio Teresi, Vincenzo Castiglione, et al.
JAMA Cardiology|March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical TrialPrem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
International Journal of Cardiology|August 2, 2025
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY)Vincenzo Castiglione, Olena Chubuchna, Giulia Elena Mandoli, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
European Heart Journal|January 18, 2020
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosisLiza Chacko, Raffaele Martone, Francesco Bandera, et al.
JACC. Cardiovascular Imaging|August 22, 2021
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin AmyloidosisFrancesco Bandera, Raffaele Martone, Liza Chacko, et al.
Giornale Italiano Di Cardiologia (2006)|February 3, 2023
[Rationale and significance of the Italian Network for Cardiac Amyloidosis]Gianfranco Sinagra, Michele Emdin, Marco Merlo, et al.
Circulation. Heart Failure|February 24, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac AmyloidosisMattia Zampieri, Giulia Biagioni, Annamaria Del Franco, et al.
The New England Journal of Medicine|January 10, 2024
Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D Gillmore, Daniel P Judge, Francesco Cappelli, et al.
Circulation. Heart Failure|May 15, 2025
High-Sensitivity Cardiac Troponin I for Risk Stratification in Wild-Type Transthyretin Amyloid CardiomyopathyLaura De Michieli, Giulio Sinigiani, Gianluigi Guida, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 5, 2023
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY studyAlberto Aimo, Lucio Teresi, Vincenzo Castiglione, et al.
JAMA Cardiology|March 30, 2026
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical TrialPrem Soman, Sarah A M Cuddy, Julian D Gillmore, et al.
ESC Heart Failure|May 14, 2021
Current patterns of beta-blocker prescription in cardiac amyloidosis: an Italian nationwide surveyGiacomo Tini, Francesco Cappelli, Elena Biagini, et al.
International Journal of Cardiology|August 2, 2025
Characteristics of patients with suspected cardiac amyloidosis in Tuscany and Umbria: Insights from the cardiac amyloidosis RegistRY (CARRY)Vincenzo Castiglione, Olena Chubuchna, Giulia Elena Mandoli, et al.
Pageof 20